Treatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide
Category
FP7 Project with U.S. partner
Short name and number
NEMO (241479)
Area
Health
Description
Neonatal hypoxic ischaemic encephalopathy (HIE) occurs in 2-3/1000 live births and is a major cause of both acute mortality and long-term neurodisability. Seizures are the hallmark of HIE.
Participating Countries
Finland, France, Germany, Ireland, Sweden, The Netherlands, United Kingdom and United States.
Name of US Partner
DUKE UNIVERSITY
Contact
UNIVERSITY COLLEGE LONDON